Senior cares are a large focus for us.
We've seen many things that come through
that population, whether, because their
immunity is suppressed, whether they're on
antibiotics that have caused C. diff.
Primarily we've been working with the
senior care market here recently.
We feel like that market has been underserved.
Bringing the QIAstat-Dx
in-house to Mako Medical expanded our test menu.
It also allowed us to bring to market an
innovative test that provides great
results for patients, so we can provide
the results quicker to patients and more
comprehensive to those patients.
The syndromic testing allows us to
cover all those bacterial and viral
markers at one time, instead
of, kind of, a guesswork approach.
We give you that, all in a 45 minute to
an hour turnaround time
once we receive that specimen at the lab.
We don't have to go back and forth and
spend a lot of time diagnosing a patient
that might not have a lot of time to get
that diagnosis, before they turn into
a septic state or anything like that.
Our major focus right now on the senior care
community is all about providing that
rapid turn around time and having those
patients avoid hospital visits.
